TheraRadar
Clinical-Stage Companies / Applied Biology

Applied Biology

Pre-Approval PRO BETA
11
Total Trials
9
Phase 3
3
Phase 2
0
Recruiting
190
Score

Pipeline by Phase

Phase 3
9
Phase 2
3
Phase 1
2

Therapeutic Focus

Androgenetic Alopecia Covid19 Chemotherapy Induced Alopecia Chemotherapy Side Effects Male Pattern Baldness

Clinical Trials (11)

NCT06762548 Phase 3 NOT YET RECRUITING

Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia

Started: 10/10/2025

NCT06745336 Phase 3 NOT YET RECRUITING

Clinical Study of CS-001 As a Treatment for Canities (Grey Hair)

Started: 6/15/2025

NCT06501924 Phase 3 NOT YET RECRUITING

Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss

Started: 1/15/2025

NCT06484881 Phase 3 WITHDRAWN

Clinical Study of Probiotic Treatment for Androgenetic Alopecia

Started: 9/15/2024

NCT05016284 Phase 3 WITHDRAWN

Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitis

Started: 11/24/2022

NCT04853134 Phase 3 WITHDRAWN

Proxalutamide Treatment for COVID-19 Female Outpatients

Started: 11/1/2020

NCT04853927 Phase 3 WITHDRAWN

Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit

Started: 2/8/2021

NCT04728802 Phase 3 COMPLETED

Proxalutamide Treatment for Hospitalized COVID-19 Patients

Started: 2/1/2021

NCT06648850 Phase 2 NOT YET RECRUITING

Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth

Started: 5/1/2026

NCT07397325 Phase 1 NOT YET RECRUITING

Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia

Started: 4/16/2026

NCT07166354 Phase 1 NOT YET RECRUITING

Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities)

Started: 10/1/2025

Drug Candidates

DA-020 Placebo DA-020 and Hyperforin DA-001 Phenylephrine Phenylephrine Topical 0.25% + Intact Pro Topical CS-002 Placebo Topical Solution DA-007 CS-001
Activity Status: Active
Last Trial Started: 5/1/2026
Last Trial Ended: 4/15/2021
Trials (12 months): 5
Completed Trials: 1
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.